General Mills

General Mills (GIS) Q1 FY2027 Earnings Preview

GIS·Q1 FY2027·

EPS estimate

0.72

Latest consensus

Revenue estimate

4.35B

Latest consensus

EPS beat probability0%
Revenue beat probability0%
GoAI outlook

Volume inflection and defensive put skew frame Q1 setup

TL;DR

  • Confirmed Date & Time: September 23, 2026, Before Market Open
  • Fiscal Quarter: Q1 FY2027
  • Consensus Estimates: EPS of $0.72 | Revenue of $4.34B
  • Options-Implied Move: +/- 5.0% (front-week straddle; wider chain models range up to 9.2%–9.9%)
  • Single Biggest Swing Factor: Organic volume performance against ongoing consumer price sensitivity and private-label trade-downs.

Setup Overview

Heading into the Q1 FY2027 release, consensus estimates for General Mills sit at $0.72 in EPS and $4.34B in net revenue, with analyst revisions trending downward leading into the print. Management reiterated its full-year FY2027 guidance on September 8, 2026, maintaining targets for adjusted EPS of $3.00–$3.20, organic net sales growth of -1.5% to +0.5%, and adjusted operating profit down 8% to 13% on a constant-currency basis.

The broader packaged food environment remains bifurcated. Peer read-throughs present a mixed picture: J.M. Smucker demonstrated resilience with an earnings beat and full-year guidance raise, whereas Hormel Foods dropped nearly 9% following a sales outlook cut driven by volume softness. Wall Street sentiment on GIS is largely defensive, characterized by Hold/Neutral/Underweight ratings and price targets concentrated between $35.00 and $43.00.


Historical Pattern

General Mills exhibits a consistent track record of EPS beats, outperforming consensus in 7 of the past 8 quarters. However, market reactions depend heavily on forward outlooks and organic volume metrics rather than top-line beats alone:

  • Q4 FY2026: Beat expectations; stock surged +8.54%.
  • Q3 FY2026: Missed expectations; stock fell -2.97%.
  • Q2 FY2026: Beat expectations; stock rose +3.38%.
  • Q1 FY2026: Beat EPS expectations; stock edged lower -0.77%.
  • Q4 FY2025: Beat EPS expectations; stock declined -5.10% due to cautious forward color.

(Note: Single-day price reactions for Q1–Q3 FY2025 were unavailable in primary research records). This pattern confirms that earnings beats without volume expansion or upward guidance revisions routinely fail to generate positive price momentum.


What to Watch

  1. Organic Net Sales & Volume vs. Price/Mix: Tracking whether top-line stability is being sustained by pricing power or if volume declines are accelerating as consumers shift toward private-label alternatives.
  2. Pet Segment Performance: Assessing recovery in the premium Blue Buffalo portfolio, which serves as a key margin driver.
  3. Guidance Durability: Monitoring whether management preserves the reiterated FY2027 range ($3.00–$3.20 EPS) or if margin pressures force a cut toward the lower bound.